Cargando…
Multiple Myeloma: What Do We Do About Immunodeficiency?
Multiple myeloma (MM) is an incurable hematological malignancy. Immunodeficiency results in the incapability of immunity to eradicate both tumor cells and pathogens. Immunotherapies along with antibiotics and other anti-infectious agents are applied as substitutes for immunity in MM. Immunotherapies...
Autores principales: | Li, Linrong, Wang, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548011/ https://www.ncbi.nlm.nih.gov/pubmed/31205523 http://dx.doi.org/10.7150/jca.29993 |
Ejemplares similares
-
What do we know about pseudodementia?
por: Mouta, Salomé, et al.
Publicado: (2023) -
A Review of the Opioid Epidemic: What Do We Do About It?
por: Shipton, Edward A., et al.
Publicado: (2018) -
Q&A: What do we know about influenza and what can we do about it?
por: Doherty, Peter C, et al.
Publicado: (2009) -
What do we know about the role of lncRNAs in multiple sclerosis?
por: Nociti, Viviana, et al.
Publicado: (2021) -
What Do We Know about Opioids and the Kidney?
por: Mallappallil, Mary, et al.
Publicado: (2017)